Stocks fall, U.S. dollar up ahead of Powell testimony

By Caroline Valetkevitch NEW YORK (Reuters) – Global stock indexes fell and the dollar index inched up on Tuesday as investors weighed the U.S. interest rate outlook ahead of Federal Reserve Chair Jerome Powell’s congressional testimony. U.S. Treasury yields eased. Adding to uncertainty over the rate outook, a report showed groundbreaking on U.S. single-family homebuilding…

Read More

Italy’s Brembo to move to Amsterdam to increase M&A options

MILAN (Reuters) – Italy’s Brembo is to move its legal headquarters to the Netherlands and strengthen its loyalty share scheme in a move aimed at increasing M&A opportunities, the premium brake maker said on Tuesday. The announcement follows similar moves by other major Italian companies, including Ferrari, Exor, Mediaset and Campari, to establish in the…

Read More

Italy gained little from Belt and Road deal with China – foreign minister

ROME (Reuters) – Italy’s participation in China’s Belt and Road Initiative (BRI) has produced few benefits, Rome’s Foreign Minister Antonio Tajani said on Tuesday, as his country faces a decision on whether to pull out of the deal. Italy in 2019 became the first and so far only G7 nation to have joined the hugely…

Read More

Analysis-Forex derivatives nudged out into the open as regulations increase costs

By Laura Matthews NEW YORK (Reuters) – Foreign-exchange investors are moving more of their over-the-counter (OTC) derivatives trades to lookalike products on exchanges to avoid higher costs due to recent global regulations, helping inject transparency into a multitrillion-dollar market that is largely hidden from the public eye. The growing interest in clearing trades through an…

Read More

Sanofi says arbitration court rejects Boehringer’s Zantac claims

By Ludwig Burger FRANKFURT (Reuters) -Sanofi said on Tuesday that the International Chamber of Commerce rejected rival drugmaker Boehringer Ingelheim’s (BI) claims to be indemnified by Sanofi in cancer lawsuits linked to heartburn drug Zantac in the United States. Shares in France’s Sanofi, which added that the decision cannot be appealed, gained 2.4% shortly after…

Read More

U.S. Justice antitrust chief details renewed bank merger scrutiny

By Pete Schroeder WASHINGTON (Reuters) -The U.S. Justice Department antitrust division plans to expand the scope of its bank merger review process, the department’s chief said on Tuesday, in a sign the agency may get tougher when scrutinizing such deals. Jonathan Kanter, the DOJ’s assistant attorney general for antitrust, said the agency’s guidelines, which were…

Read More

Exclusive-Tesla standard: BTC Power joins move to add to EV chargers

By Abhirup Roy SAN FRANCISCO (Reuters) – BTC Power will add Tesla’s standard to its electric vehicle chargers next year, its chief executive told Reuters on Tuesday, days after Ford and General Motors sent shockwaves through the industry by adopting the technology. Privately-owned BTC, a supplier to 7-Eleven and fleet operators, is the fourth major…

Read More